High glucose enhances aggressiveness of EGFR-amplified non-small cell lung cancer via EGFR/STAT3 signaling pathway

被引：0
|
作者：
Sorin, Supannika [1 ,2 ]
Zhou, Yubin [3 ,4 ]
Pilamas, Urupong [1 ,2 ]
Wongkham, Sopit [1 ,2 ]
Saengboonmee, Charupong [1 ,2 ]
机构：
[1] Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand
[2] Khon Kaen Univ, Ctr Translat Med, Fac Med, Khon Kaen, Thailand
[3] Univ Elect Sci & Tech China, Thorac Surg, Chengdu, Peoples R China
[4] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Beijing, Peoples R China
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1179
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [1] EGFR transcriptionally upregulates UTX via STAT3 in non-small cell lung cancer
    Lin Zhou
    Xiaomu Wang
    Jingya Lu
    Xiangning Fu
    Yangkai Li
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 309 - 319
  • [2] EGFR transcriptionally upregulates UTX via STAT3 in non-small cell lung cancer
    Zhou, Lin
    Wang, Xiaomu
    Lu, Jingya
    Fu, Xiangning
    Li, Yangkai
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (02) : 309 - 319
  • [3] Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway
    Li, Wei
    Yu, Xinfang
    Tan, Shiming
    Liu, Wenbin
    Zhou, Li
    Liu, Haidan
    CANCER MEDICINE, 2018, 7 (01): : 208 - 218
  • [4] The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
    Zhang, Nan
    Zeng, Yuanyuan
    Du, Wenwen
    Zhu, Jianjie
    Shen, Dan
    Liu, Zeyi
    Huang, Jian-An
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) : 1360 - 1368
  • [5] Activation state (phosphorylated) EGFR and STAT3 as prognostic markers in resected non-small cell lung cancer (NSCLC).
    Cortas, T
    Eisenberg, R
    Fu, P
    Robke, J
    Kern, JA
    Dowlati, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 642S - 642S
  • [6] Induction of apoptosis by morusin in human non-small cell lung cancer cells by suppression of EGFR/STAT3 activation
    Park, Hyun-Ji
    Min, Tae-Rin
    Chi, Gyoo-Yong
    Choi, Yung-Hyun
    Park, Shin-Hyung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (01) : 194 - 200
  • [7] Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells
    Saygideger-Kont, Yasemin
    Minas, Tsion Zewdu
    Jones, Hayden
    Hour, Sarah
    Celik, Haydar
    Temel, Idil
    Han, Jenny
    Atabey, Nese
    Erkizan, Hayriye Verda
    Toretsky, Jeffrey A.
    Uren, Aykut
    NEOPLASIA, 2016, 18 (02): : 111 - 120
  • [8] STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells
    Wang, Qian
    Lu, Bing
    Zhang, Yi
    Yu, Jing
    Guo, Jie
    Zhou, Qianchi
    Lv, Hong
    Sun, Yifeng
    HUMAN CELL, 2021, 34 (06) : 1855 - 1865
  • [9] STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells
    Qian Wang
    Bing Lu
    Yi Zhang
    Jing Yu
    Jie Guo
    Qianchi Zhou
    Hong Lv
    Yifeng Sun
    Human Cell, 2021, 34 : 1855 - 1865
  • [10] The Role of STAT3 in Non-Small Cell Lung Cancer
    Harada, Daijiro
    Takigawa, Nagio
    Kiura, Katsuyuki
    CANCERS, 2014, 6 (02): : 708 - 722
12345